Ciruelos, Eva <br/><br/>
Role of inhibitors of mammalian target of rapamycin in the treatment of luminal breast cancer.  [electronic resource] 

 -  Anti-cancer drugs  Sep 2013 
 - 769-80 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1473-5741 
<br/><br/><label>Standard No.: </label>10.1097/CAD.0b013e328363adc5  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Androstadienes--administration & dosage<br/>Animals<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Aromatase Inhibitors--administration & dosage<br/>Biomarkers, Tumor--metabolism<br/>Breast Neoplasms--drug therapy<br/>Disease-Free Survival<br/>Everolimus<br/>Female<br/>Humans<br/>Molecular Targeted Therapy<br/>Protein Kinase Inhibitors--administration & dosage<br/>Signal Transduction--drug effects<br/>Sirolimus--administration & dosage<br/>TOR Serine-Threonine Kinases--antagonists & inhibitors<br/>Treatment Outcome